1. Home
  2. CLDI vs BNAI Comparison

CLDI vs BNAI Comparison

Compare CLDI & BNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDI
  • BNAI
  • Stock Information
  • Founded
  • CLDI 2014
  • BNAI 2018
  • Country
  • CLDI United States
  • BNAI United States
  • Employees
  • CLDI N/A
  • BNAI N/A
  • Industry
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • BNAI
  • Sector
  • CLDI Health Care
  • BNAI
  • Exchange
  • CLDI Nasdaq
  • BNAI NYSE
  • Market Cap
  • CLDI 20.2M
  • BNAI 20.7M
  • IPO Year
  • CLDI N/A
  • BNAI N/A
  • Fundamental
  • Price
  • CLDI $0.59
  • BNAI $0.34
  • Analyst Decision
  • CLDI
  • BNAI Strong Buy
  • Analyst Count
  • CLDI 0
  • BNAI 1
  • Target Price
  • CLDI N/A
  • BNAI $6.00
  • AVG Volume (30 Days)
  • CLDI 51.3M
  • BNAI 580.0K
  • Earning Date
  • CLDI 08-12-2025
  • BNAI 08-13-2025
  • Dividend Yield
  • CLDI N/A
  • BNAI N/A
  • EPS Growth
  • CLDI N/A
  • BNAI N/A
  • EPS
  • CLDI N/A
  • BNAI N/A
  • Revenue
  • CLDI N/A
  • BNAI $60,000.00
  • Revenue This Year
  • CLDI N/A
  • BNAI N/A
  • Revenue Next Year
  • CLDI N/A
  • BNAI N/A
  • P/E Ratio
  • CLDI N/A
  • BNAI N/A
  • Revenue Growth
  • CLDI N/A
  • BNAI N/A
  • 52 Week Low
  • CLDI $0.20
  • BNAI $0.23
  • 52 Week High
  • CLDI $3.89
  • BNAI $2.64
  • Technical
  • Relative Strength Index (RSI)
  • CLDI 51.83
  • BNAI 48.24
  • Support Level
  • CLDI $0.56
  • BNAI $0.32
  • Resistance Level
  • CLDI $0.91
  • BNAI $0.37
  • Average True Range (ATR)
  • CLDI 0.10
  • BNAI 0.03
  • MACD
  • CLDI -0.02
  • BNAI 0.00
  • Stochastic Oscillator
  • CLDI 27.34
  • BNAI 56.34

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

About BNAI BRAND ENGAGEMENT NETWORK INC

Brand Engagement Network Inc is a generative AI (GenAI) company specializing in conversational AI solutions. Through its secure, human-like AI agents, available in different modalities, the company seeks to transform consumer engagement and elevate customer experience, productivity, and business performance.

Share on Social Networks: